BioLargo CEO Dennis Calvert joined Proactive's Natalie Stoberman to share more details of the addition of Nicholas Valeriani and Linda Park to the board of directors of subsidiary Clyra Medical Technologies.
BioLargo noted that Valeriani has decades of executive experience in the medical device industry. He spent 34 years at Johnson & Johnson, where he led several corporate functions and was a member of its executive committee.
Park is a trusted executive and legal professional with a proven track record of supporting and advising public companies at the corporate board and executive level at billion-dollar corporations.
Proactive USA
+1 347-449-0879
na-editorial@proactiveinvestors.com
| Last Trade: | US$0.21 |
| Daily Change: | -0.005 -2.38 |
| Daily Volume: | 498,051 |
| Market Cap: | US$61.740M |
May 13, 2025 May 05, 2025 January 15, 2025 | |
